Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Anderson

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Neuropsychologia|November 10, 2018
Reduction in lower-alpha power during Ganzfeld flicker stimulation is associated with the production of imagery and trait positive schizotypyAlex Sumich, John D Anderson, Christina J Howard, et al.
Science (New York, N.Y.)|August 18, 2004
Discovery of mass anomalies on GanymedeJohn D Anderson, Gerald Schubert, Robert A Jacobson, et al.
The Lancet. Global Health|May 18, 2023
Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling studyChloe Puett, John D Anderson, Karoun H Bagamian, et al.
The Lancet. Global Health|November 18, 2019
Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stuntingKaroun H Bagamian, John D Anderson, Farzana Muhib, et al.
The Lancet. Global Health|February 21, 2019
Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysisJohn D Anderson, Karoun H Bagamian, Farzana Muhib, et al.
Vaccine: X|August 7, 2019
Potential impact and cost-effectiveness of future ETEC and <i>Shigella</i> vaccines in 79 low- and lower middle-income countriesJohn D Anderson, Karoun H Bagamian, Farzana Muhib, et al.
The Lancet. Global Health|May 18, 2023
Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling studyJohn D Anderson, Karoun H Bagamian, Clint J Pecenka, et al.
Vaccine|July 16, 2018
Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in PakistanRichard Rheingans, John D Anderson, Karoun H Bagamian, et al.
Vaccine|October 12, 2023
Vaccine value profile for ShigellaWilliam P Hausdorff, John D Anderson, Karoun H Bagamian, et al.
Frontiers in Microbiology|February 23, 2018
A Microfluidics and Agent-Based Modeling Framework for Investigating Spatial Organization in Bacterial Colonies: The Case of <i>Pseudomonas Aeruginosa</i> and H1-Type VI Secretion InteractionsJared L Wilmoth, Peter W Doak, Andrea Timm, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neuropsychologia|November 10, 2018
Reduction in lower-alpha power during Ganzfeld flicker stimulation is associated with the production of imagery and trait positive schizotypyAlex Sumich, John D Anderson, Christina J Howard, et al.
Science (New York, N.Y.)|August 18, 2004
Discovery of mass anomalies on GanymedeJohn D Anderson, Gerald Schubert, Robert A Jacobson, et al.
The Lancet. Global Health|May 18, 2023
Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling studyChloe Puett, John D Anderson, Karoun H Bagamian, et al.
The Lancet. Global Health|November 18, 2019
Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stuntingKaroun H Bagamian, John D Anderson, Farzana Muhib, et al.
The Lancet. Global Health|February 21, 2019
Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysisJohn D Anderson, Karoun H Bagamian, Farzana Muhib, et al.
Vaccine: X|August 7, 2019
Potential impact and cost-effectiveness of future ETEC and <i>Shigella</i> vaccines in 79 low- and lower middle-income countriesJohn D Anderson, Karoun H Bagamian, Farzana Muhib, et al.
The Lancet. Global Health|May 18, 2023
Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling studyJohn D Anderson, Karoun H Bagamian, Clint J Pecenka, et al.
Vaccine|July 16, 2018
Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in PakistanRichard Rheingans, John D Anderson, Karoun H Bagamian, et al.
Vaccine|October 12, 2023
Vaccine value profile for ShigellaWilliam P Hausdorff, John D Anderson, Karoun H Bagamian, et al.
Frontiers in Microbiology|February 23, 2018
A Microfluidics and Agent-Based Modeling Framework for Investigating Spatial Organization in Bacterial Colonies: The Case of <i>Pseudomonas Aeruginosa</i> and H1-Type VI Secretion InteractionsJared L Wilmoth, Peter W Doak, Andrea Timm, et al.
Pageof 5